127 related articles for article (PubMed ID: 12381481)
21. Reversible contraception for the woman over 35 years of age.
Archer DF
Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
[TBL] [Abstract][Full Text] [Related]
22. Involution of latent endometrial precancers by hormonal and nonhormonal mechanisms.
Lin MC; Burkholder KA; Viswanathan AN; Neuberg D; Mutter GL
Cancer; 2009 May; 115(10):2111-8. PubMed ID: 19280590
[TBL] [Abstract][Full Text] [Related]
23. Modelling body mass index and endometrial cancer risk in a pooled-analysis of three case-control studies.
Rota M; Rumi F; Bagnardi V; Dal Maso L; Zucchetto A; Levi F; La Vecchia C; Tavani A
BJOG; 2016 Jan; 123(2):285-92. PubMed ID: 26541752
[TBL] [Abstract][Full Text] [Related]
24. A clinicopathological study of IUD users with special reference to endometrial patterns and endometritis.
van Bogaert LJ
Gynecol Obstet Invest; 1983; 16(3):129-35. PubMed ID: 6618283
[TBL] [Abstract][Full Text] [Related]
25. [Intrauterine contraception in nulliparous women].
Prilepskaia VN; Mezhevitinova EA
Akush Ginekol (Mosk); 1991 Apr; (4):5-8. PubMed ID: 1862876
[TBL] [Abstract][Full Text] [Related]
26. [Clinical study of intrauterine contraceptives].
Parshina LA; Konishcheva OE
Akush Ginekol (Mosk); 1977 Dec; (12):39-40. PubMed ID: 605979
[TBL] [Abstract][Full Text] [Related]
27. Immunologic evaluation of the endometrium with a levonorgestrel intrauterine device in solid organ transplant women and healthy controls.
Kim CR; Martinez-Maza O; Magpantay L; Magyar C; Gornbein J; Rible R; Sullivan P
Contraception; 2016 Nov; 94(5):534-540. PubMed ID: 27374735
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of endometriosis in women attending family planning clinics.
Vessey MP; Villard-Mackintosh L; Painter R
BMJ; 1993 Jan; 306(6871):182-4. PubMed ID: 8338516
[TBL] [Abstract][Full Text] [Related]
29. The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort study.
Laaksonen MA; Arriaga ME; Canfell K; MacInnis RJ; Byles JE; Banks E; Shaw JE; Mitchell P; Giles GG; Magliano DJ; Gill TK; Klaes E; Velentzis LS; Hirani V; Cumming RG; Vajdic CM
Gynecol Oncol; 2019 Jun; 153(3):580-588. PubMed ID: 30935715
[TBL] [Abstract][Full Text] [Related]
30. Copper levels in women using intrauterine devices or oral contraceptives.
Hefnawi F; Kandil O; Askalani H; Zaki K; Nasr F; Mousa M
Fertil Steril; 1974 Jul; 25(7):556-61. PubMed ID: 4841618
[TBL] [Abstract][Full Text] [Related]
31. Decreased endometrial HOXA10 expression associated with use of the copper intrauterine device.
Tetrault AM; Richman SM; Fei X; Taylor HS
Fertil Steril; 2009 Dec; 92(6):1820-4. PubMed ID: 18930214
[TBL] [Abstract][Full Text] [Related]
32. "Older" age is a risk factor for pelvic inflammatory disease in intrauterine device users.
Viberga I; Odlind V; Berglund L
Acta Obstet Gynecol Scand; 2005 Dec; 84(12):1202-7. PubMed ID: 16305709
[TBL] [Abstract][Full Text] [Related]
33. Effects of the intrauterine contraceptive device on endometrial enzyme and carbohydrate histochemistry.
Hester LL; Kellett WW; Spicer SS; Williamson HO; Pratt-Thomas HR
Am J Obstet Gynecol; 1970 Apr; 106(8):1144-54. PubMed ID: 4314520
[TBL] [Abstract][Full Text] [Related]
34. Intrauterine device use and the risk of pre-eclampsia: a case-control study.
Parker SE; Jick SS; Werler MM
BJOG; 2016 Apr; 123(5):788-95. PubMed ID: 25854682
[TBL] [Abstract][Full Text] [Related]
35. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
Vessey MP; Lawless M; McPherson K; Yeates D
Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
[TBL] [Abstract][Full Text] [Related]
36. [Endometrial morphological changes in intrauterine device users].
Viero F; Angeli G; Chinaglia D; Porcelli A; Surico N
Minerva Ginecol; 1986; 38(7-8):613-9. PubMed ID: 3748442
[TBL] [Abstract][Full Text] [Related]
37. The evaluation of the data collection process for a multicenter, population-based, case-control design.
Wingo PA; Ory HW; Layde PM; Lee NC
Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827
[TBL] [Abstract][Full Text] [Related]
38. Use of oral contraceptives and endometrial cancer risk (Sweden).
Weiderpass E; Adami HO; Baron JA; Magnusson C; Lindgren A; Persson I
Cancer Causes Control; 1999 Aug; 10(4):277-84. PubMed ID: 10482486
[TBL] [Abstract][Full Text] [Related]
39. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies.
Castellsagué X; Díaz M; Vaccarella S; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Meijer CJ; Bosch FX
Lancet Oncol; 2011 Oct; 12(11):1023-31. PubMed ID: 21917519
[TBL] [Abstract][Full Text] [Related]
40. Contraception and the etiology of pelvic inflammatory disease: new perspectives.
Senanayake P; Kramer DG
Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 2):852-60. PubMed ID: 7008602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
